marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Plus Therapeutics Balance Sheet 2011-2024 | PSTV
Annual Balance Sheet Plus Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-8.35 M | -14.2 M | -13.3 M | -1.48 M | -5.58 M | 8.94 M | 4.07 M | 5.08 M | 4.09 M | 10.8 M | 10.8 M | -3.03 M | -12.5 M |
Long Term Debt |
85 K | 3.79 M | 5 M | 528 K | - | - | - | 11 M | 16.7 M | 18 M | 23.1 M | 12.9 M | 22 M |
Long Term Debt Current |
120 K | 110 K | 111 K | 123 K | 147 K | 14.2 M | 13.6 M | 6.63 M | - | 7.36 M | 3.19 M | 9.78 M | 2.49 M |
Total Non Current Liabilities |
- | - | - | 535 K | 7.58 M | 1.21 M | 201 K | 11.1 M | 17.1 M | 28.5 M | 24 M | 19.2 M | 33.8 M |
Total Current Liabilities |
10.7 M | 11.9 M | 5.87 M | 8.54 M | 14.5 M | 17.6 M | 18.4 M | 12.5 M | 8.44 M | 15.9 M | 14.9 M | 17.6 M | 7.82 M |
Total Liabilities |
12.7 M | 17.4 M | 11.1 M | 9.07 M | 22.1 M | 18.8 M | 18.6 M | 23.6 M | 25.5 M | 44.4 M | 38.9 M | 36.8 M | 41.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | 215 K | 221 K | 191 K | 138 K | 35 K | - |
Retained Earnings |
-481 M | -467 M | -447 M | -434 M | -425 M | -414 M | -402 M | -379 M | -357 M | -338 M | -301 M | -275 M | -242 M |
Total Assets |
11.4 M | 23.9 M | 22 M | 12.1 M | 23.2 M | 24 M | 31.6 M | 34.6 M | 37.7 M | 38.7 M | 42.1 M | 43.2 M | 51.5 M |
Cash and Cash Equivalents |
8.55 M | 18.1 M | 18.4 M | 8.35 M | 17.6 M | 5.26 M | 9.55 M | 12.6 M | 14.3 M | 14.6 M | 15.5 M | 25.7 M | 36.9 M |
Book Value |
-1.35 M | 6.44 M | 10.8 M | 3.03 M | 1.16 M | 5.22 M | 13 M | 11 M | 12.2 M | -5.7 M | 3.13 M | 6.46 M | 9.95 M |
Total Shareholders Equity |
-1.35 M | 6.44 M | 10.8 M | 3.03 M | 1.16 M | 5.22 M | 13 M | 11 M | 12.2 M | -5.7 M | 3.13 M | 6.46 M | 9.95 M |
All numbers in USD currency
Quarterly Balance Sheet Plus Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
40 K | 50 K | 59 K | 85 K | 118 K | 136 K | 166 K | 3.79 M | 4.11 M | 4.42 M | 4.72 M | 5 M | 504 K | 530 K | 5 M | 528 K | 528 K | 528 K | 4 K | 8 K | 38 K | 54 K | 85 K | - | - | - | - | - | - | 7.77 M | 9.4 M | 11 M | 11 M | 11 M | 11 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 18 M | 18 M | 18 M | 18 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 22 M | 22 M | 22 M | 22 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
12.2 M | 18.8 M | 10.5 M | 12.7 M | 10.7 M | 11.5 M | 13 M | 17.4 M | 11.7 M | 11.6 M | 9.87 M | 11.1 M | 10 M | 8.89 M | 11.1 M | 9.07 M | 9.07 M | 9.07 M | 9.07 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 25.5 M | 25.5 M | 25.5 M | 25.5 M | 44.4 M | 44.4 M | 44.4 M | 44.4 M | 38.9 M | 38.9 M | 38.9 M | 38.9 M | 36.8 M | 36.8 M | 36.8 M | 36.8 M | 41.6 M | 41.6 M | 41.6 M | 41.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-490 M | -487 M | -484 M | -481 M | -477 M | -473 M | -472 M | -467 M | -462 M | -456 M | -451 M | -447 M | -443 M | -439 M | -447 M | -434 M | -434 M | -434 M | -434 M | -425 M | -425 M | -425 M | -425 M | -414 M | -414 M | -414 M | -414 M | -402 M | -402 M | -402 M | -402 M | -379 M | -379 M | -379 M | -379 M | -357 M | -357 M | -357 M | -357 M | -338 M | -338 M | -338 M | -338 M | -301 M | -301 M | -301 M | -301 M | -275 M | -275 M | -275 M | -275 M | -242 M | -242 M | -242 M | -242 M |
Total Assets |
6.98 M | 11.2 M | 5.62 M | 11.4 M | 13.3 M | 14.2 M | 15.6 M | 23.9 M | 23.1 M | 21.3 M | 24.5 M | 22 M | 24.8 M | 20.8 M | 22 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 23.2 M | 23.2 M | 23.2 M | 23.2 M | 24 M | 24 M | 24 M | 24 M | 31.6 M | 31.6 M | 31.6 M | 31.6 M | 34.6 M | 34.6 M | 34.6 M | 34.6 M | 37.7 M | 37.7 M | 37.7 M | 37.7 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M | 42.1 M | 42.1 M | 42.1 M | 42.1 M | 43.2 M | 43.2 M | 43.2 M | 43.2 M | 51.5 M | 51.5 M | 51.5 M | 51.5 M |
Cash and Cash Equivalents |
1.22 M | 4.91 M | 2.9 M | 8.55 M | 11 M | 10.9 M | 12.7 M | 18.1 M | 20.3 M | 18.1 M | 21.2 M | 18.4 M | 21.3 M | 17.2 M | 18.4 M | 8.35 M | 8.35 M | 8.35 M | 8.35 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 5.26 M | 5.26 M | 5.26 M | 5.26 M | 9.55 M | 9.55 M | 9.55 M | 9.55 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 25.7 M | 25.7 M | 25.7 M | 25.7 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M |
Book Value |
-5.17 M | -7.62 M | -4.84 M | -1.35 M | 2.62 M | 2.66 M | 2.68 M | 6.44 M | 11.4 M | 9.68 M | 14.6 M | 10.8 M | 14.8 M | 11.9 M | 10.8 M | 3.03 M | 3.03 M | 3.03 M | 3.03 M | 1.16 M | 1.16 M | 1.16 M | 1.16 M | 5.22 M | 5.22 M | 5.22 M | 5.22 M | 13 M | 13 M | 13 M | 13 M | 11 M | 11 M | 11 M | 11 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | -5.7 M | -5.7 M | -5.7 M | -5.7 M | 3.13 M | 3.13 M | 3.13 M | 3.13 M | 6.46 M | 6.46 M | 6.46 M | 6.46 M | 9.95 M | 9.95 M | 9.95 M | 9.95 M |
Total Shareholders Equity |
-5.17 M | -7.62 M | -4.84 M | -1.35 M | 2.62 M | 2.66 M | 2.68 M | 6.44 M | 11.4 M | 9.68 M | 14.6 M | 10.8 M | 14.8 M | 11.9 M | 9.51 M | 3.03 M | 3.03 M | 3.03 M | 3.03 M | 1.16 M | 1.16 M | 1.16 M | 1.16 M | 5.22 M | 5.22 M | 5.22 M | 5.22 M | 13 M | 13 M | 13 M | 13 M | 11 M | 11 M | 11 M | 11 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | -5.7 M | -5.7 M | -5.7 M | -5.7 M | 3.13 M | 3.13 M | 3.13 M | 3.13 M | 6.46 M | 6.46 M | 6.46 M | 6.46 M | 9.95 M | 9.95 M | 9.95 M | 9.95 M |
All numbers in USD currency